CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence
Hongo, Fumiya, M.D., Ph.D, Takaha, Natsuki, M.D., Ph.D, Oishi, Masakatsu, M.D., Ph.D, Ueda, Takashi, M.D., Ph.D, Nakamura, Terukazu, M.D., Ph.D, Naitoh, Yasuyuki, M.D., Ph.D, Naya, Yoshio, M.D., Ph.D, Kamoi, Kazumi, M.D., Ph.D, Okihara, Koji, M.D., Ph.D, Matsushima, Tomoko, Ph.D, Nakayama, Satoshi, Ph.D, Ishihara, Hideki, Ph.D, Sakai, Toshiyuki, M.D., Ph.D, Miki, Tsuneharu, M.D., Ph.D
Published in Urologic oncology (01.11.2014)
Published in Urologic oncology (01.11.2014)
Get full text
Journal Article